P714 Vedolizumab, an adequate option in medically...

Journal of Crohn's and Colitis 2018 / 01 Vol. 12; Iss. supplement

P714 Vedolizumab, an adequate option in medically refractory and thiopurine-intolerant inflammatory bowel disease patients

Iborra, M, Maroto, N, Navarro-Cortes, P, Beltran, B, Boscá-Watts, M, Ferrer, I, Garcia-Morales, N, Sáez-González, E, Hinojosa, J, Minguez, M, Nos, P
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.841
Date:
January, 2018
File:
PDF, 346 KB
english, 2018
Conversion to is in progress
Conversion to is failed